User contributions
Jump to navigation
Jump to search
- 12:16, 17 May 2020 diff hist +328 N World Health Organization cited as Ref 2 in DOI: 10.1080/22221751.2020.1735265 current
- 19:05, 14 May 2020 diff hist +718 N Disclosure statement (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +1,098 N Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +1,931 N Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +1,070 N Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +907 N Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +972 N Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +913 N Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +1,371 N Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +1,025 N Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +918 N Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +947 N Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +683 N Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +981 N Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +1,311 N Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) current
- 19:05, 14 May 2020 diff hist +954 N Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +1,447 N Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +1,219 N Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265)
- 19:05, 14 May 2020 diff hist +785 N Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265)
- 19:04, 14 May 2020 diff hist +1,859 N Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265)
- 19:04, 14 May 2020 diff hist +1,103 N Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265)
- 19:04, 14 May 2020 diff hist +770 N Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265)
- 19:04, 14 May 2020 diff hist +1,534 N Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265)
- 19:04, 14 May 2020 diff hist +1,034 N Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265)
- 19:04, 14 May 2020 diff hist +1,392 N Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265)
- 19:04, 14 May 2020 diff hist +763 N Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265)
- 15:23, 5 May 2020 diff hist +2,369 N Conclusions section from DOI: 10.1186/s13613-020-00653-z current
- 15:23, 5 May 2020 diff hist +2,369 N Discussion section from DOI: 10.1186/s13613-020-00653-z current
- 15:23, 5 May 2020 diff hist +2,369 N Results section from DOI: 10.1186/s13613-020-00653-z current
- 15:23, 5 May 2020 diff hist +2,369 N Methods section from DOI: 10.1186/s13613-020-00653-z current
- 20:58, 4 May 2020 diff hist +78 N Jun Duan (5th author of DOI 10.1186/s13613-020-00653-z) current
- 20:58, 4 May 2020 diff hist +78 N Weiwei Shu (4th author of DOI 10.1186/s13613-020-00653-z) current
- 20:58, 4 May 2020 diff hist +78 N Ji Li (3rd author of DOI 10.1186/s13613-020-00653-z) current
- 20:58, 4 May 2020 diff hist +78 N Wei Zhao (2nd author of DOI 10.1186/s13613-020-00653-z) current
- 19:07, 15 April 2020 diff hist +193 N Reference 64 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 63 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 62 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 61 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 60 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 59 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 58 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 57 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 56 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 55 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 54 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 53 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 52 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 51 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 49 in the bibliography for DOI: 10.3390/pathogens9020148 current
- 19:07, 15 April 2020 diff hist +193 N Reference 48 in the bibliography for DOI: 10.3390/pathogens9020148 current
